The Age, July19th 2017 – 8:32 AM A critically drug-resistant strain of gonorrhoea dubbed a “super-superbug” has been detected in every Australian state and territory by a new national surveillance system. The National Alert System for Critical Antimicrobial Resistance (CARAlert) identified 1,064 bacteria highly resistant to last-line antibiotics between 17 March 2016 and 31...
Australian Journal of Pharmacy online, 15 Feb, 2017 The Medicines Classification Committee recommendation follows an application by Green Cross Health and Natalie Gauld Ltd to have the contraceptives downscheduled from prescription to “restricted” medicines. Medsafe Group Manager Chris James says this will mean pharmacists can sell up to six months’ supply of oral contraceptives to women who meet...
Health Consumers Alliance of South Australia, 2017 The Department for Health and Ageing is seeking feedback on a proposed patient access pathway for medical cannabis in South Australia. A discussion paper has been released which proposes a patient access pathway including amendments to South Australian controlled substances legislation, to ensure national consistency towards safe and appropriate...
SHine SA, October 2016 SHine SA and Family Planning Alliance Australia put in submissions to the TGA for the rescheduling of ulipristal acetate (EllaOne®), a new emergency contraceptive pill in Australia. The rescheduling is from prescription-only to Schedule 3 (available in pharmacies with a pharmacy consultation). This has now been approved, to take place from February 2017. This is an...
ASHM, October 2016 Upon successful completion of this training and the associated case assessment, medical practitioners may apply to the relevant State Department of health for authority to prescribe section 100 drugs for the management of HIV in Australia. Please note that the Introduction to HIV Care for General Practitioners is a pre-requisite for this course. This is an online course and you...
Journal of the International AIDS Society 2016, 19:21165 Abstract: Introduction: An estimated 1.2 million Americans have indications for using antiretroviral pre-exposure prophylaxis (PrEP) to prevent HIV acquisition. For many of these at-risk individuals, the best opportunity to learn about and receive PrEP will be during routine visits to their generalist primary care clinicians. However, few...